Click here to create your personal news page. The news that appears on EXEL will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.  

topics : related - allExplore

Shopping Categories

  1. 1. Digital Camera
  2. 2. LCD Monitor
  3. 3. Mobile Phone
  4. 4. LCD TV
  5. 5. Laptop Computer
  6. 6. Graphic Card
  7. 7. Smartphone
  8. 8. Fridge
  9. 9. Freezer
  10. 10. Vacuum Cleaner
  11. 11. Digital Camcorder
  12. 12. Processor
  13. 13. Washing Machine
  14. 14. Microwave
  15. 15. Coffee Maker & Expresso

Wikio Shopping

  1. 1. Baby & Nursery
  2. 2. Car/Motor Bike
  3. 3. Communication
  4. 4. Computers
  5. 5. Electronics
  6. 6. Entertainment
  7. 7. Fashion & Lingerie
  8. 8. Finance
  9. 9. Gifts & Gadgets
  10. 10. Health & Beauty
  11. 11. Home & Garden
  12. 12. Household Appliances
  13. 13. Sport & Fitness
  14. 14. Travel
  15. 15. Video Games

Participate

News Categories



EXEL



Sort by : relevance - date
+Vote!

Exel Change Management Dashboard

Projects and Change 2.0 (Free subscription) | 5 hours ago

OCM Dashboard Publish at Scribd or explore others: Management Business oracle sap

+Vote!

Exel Change Readiness Workbook

Projects and Change 2.0 (Free subscription) | 5 hours ago

Change Readiness Excel Workbook Publish at Scribd or explore others: Management Business excel Macro

+Vote!

Importing exel data

Vista Forums (Free subscription) | 01/12/2008

Can someone tell me why I post a question about importing data and the next day when I look for an answer my question is completely gone?? Thanks! -- Geno

+Vote!

Exelixis And Bristol-Myers Squibb To Co-Develop XL413, A Selective Cdc7 Inhibitor

Medical News Today (Free subscription) | 25/11/2008

Exelixis, Inc. (Nasdaq:EXEL) today announced that Bristol-Myers Squibb Company (NYSE:BMY) has exercised its option to develop and commercialize Exelixis' investigational new drug (IND) candidate XL413, a selective inhibitor of Cdc7.